Insider · CIK 0001906486
Jason B. Daly
Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing Nov 19, 2024, latest Mar 7, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMRX: Amneal Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 72Notable | Amneal Pharmaceuticals, Inc. | $792k 90,000 shares | -73% | +17% from low-3% from high | |
| 60Notable | Amneal Pharmaceuticals, Inc. | $115k 13,665 shares | -100% | - | |
| 66Notable | Amneal Pharmaceuticals, Inc. | $376k 43,657 shares | -76% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -43,064 | $8.88 | $382k | 79,542 | Mar 7, 2025 |
| Mar 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -46,936 | $8.73 | $410k | 32,606 | Mar 7, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +22,645 | - | - | 22,645 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -6,943 | $8.76 | $61k | 15,702 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +38,226 | - | - | 53,928 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -10,864 | $8.76 | $95k | 43,064 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +90,580 | - | - | 133,644 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -31,338 | $8.76 | $275k | 102,306 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +35,879 | - | - | 138,185 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | FTax withholding Class A Common Stock | -15,579 | $8.84 | $138k | 122,606 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -22,645 | $0.00 | $0 | 22,645 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -38,226 | $0.00 | $0 | 76,453 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Performance-Based Restricted Stock Unitsderivative | -90,580 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Performance-Based Restricted Stock Unitsderivative | +194,064 | $0.00 | $0 | 194,064 | Mar 5, 2025 |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +97,032 | $0.00 | $0 | 97,032 | Mar 5, 2025 |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -35,879 | $0.00 | $0 | 107,640 | Mar 5, 2025 |
| Nov 21, 2024 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -13,665 | $8.40 | $115k | 0 | Nov 22, 2024 |
| Nov 15, 2024 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -43,657 | $8.61 | $376k | 13,665 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.